Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Complete Blood Count Device Market Forecast: Value Set To Climb From $4.58 Billion To $5.76 Billion#_x000D_
The market for complete blood count devices has shown robust expansion in size over recent years. This market is forecast to increase from $4.33 billion in 2025 to $4.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. The historical growth can be primarily ascribed to the expansion of clinical diagnostic testing volumes, heightened automation in hospital laboratories, the increasing burden of chronic diseases, the widespread availability of standardized blood testing protocols, and a rising demand for routine health screenings._x000D_
_x000D_
The complete blood count device market is anticipated to undergo significant expansion in the coming years. Its valuation is projected to reach $5.76 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This market expansion throughout the forecast period stems from factors such as the increasing integration of decentralized diagnostics, heightened investments in intelligent laboratory infrastructure, an escalating need for swift diagnostic outcomes, the broadening scope of preventive healthcare screenings, and continuous progress in hematology technology. Noteworthy trends for the forecast duration encompass the increasing deployment of automated hematology analyzers, an escalating requirement for point-of-care complete blood count devices, the expanding incorporation of AI-driven diagnostics, the growth of high-throughput laboratory systems, and a more pronounced focus on diagnostic precision and speed._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Complete Blood Count Device Market Development Factors: What’s Supporting Demand?#_x000D_
The increasing occurrence of blood disorders is anticipated to boost the expansion of the complete blood count device market. These conditions are health issues that interfere with the production, operation, or structure of blood cells, leading to compromised blood function. The uptick in blood disorders is connected to the rising incidence of lifestyle-related ailments, where factors like inadequate diet, lack of physical activity, and stress contribute to issues such as anemia and blood clotting problems. A complete blood count (CBC) device assists in detecting blood disorders through the examination of vital blood components and the identification of irregularities, enabling medical professionals to spot clotting conditions and provide swift and accurate treatment. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based organization, 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the rising prevalence of blood disorders is fueling the growth of the complete blood count device market._x000D_
_x000D_
#Complete Blood Count Device Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The complete blood count device market covered in this report is segmented – _x000D_
_x000D_
1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers_x000D_
2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types_x000D_
3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy_x000D_
4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers_x000D_
5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers_x000D_
2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents_x000D_
3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits_x000D_
4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers_x000D_
_x000D_
#Complete Blood Count Device Market Transformation Trends: What Innovations Are Driving Change?#_x000D_
Leading companies in the complete blood count device market are concentrating on creating advanced products, such as compact hematology analyzers, to offer more precise, quicker, and economical solutions for point-of-care testing. Compact hematology analyzers are mobile, simple-to-use instruments that deliver fast, accurate complete blood count (CBC) outcomes with minimal sample volume, rendering them ideal for point-of-care applications, thereby boosting diagnostic precision, operational effectiveness, and user convenience while remaining cost-efficient and straightforward to maintain. For example, in June 2024, HORIBA, a Japan-based analytical and measurement technology firm, unveiled the Yumizen H550E and H500E hematology analyzers. These compact instruments incorporate erythrocyte sedimentation rate (ESR) testing alongside complete blood count (CBC) and 5-part differential (DIFF) analysis, employing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide thorough results from whole blood samples in just 60 seconds._x000D_
_x000D_
#Complete Blood Count Device Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd. _x000D_
_x000D_
#View The Full Complete Blood Count Device Market Report:#_x000D_
_x000D_
#Complete Blood Count Device Market Global Footprint: Which Region Leads The Industry?#_x000D_
North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.